Aug 15, 2019, 08:28 AM by Michael Croft

WESTBURY, NY - Aug 15, 2019 - BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that researchers in its Transporter Sciences Group have co-authored a peer-reviewed DMD paper, which investigates the inhibitory effects of a class of HIV drugs known as integrase inhibitors on folate transporter pathways

Aug 14, 2019, 12:15 PM by Michael Croft

GUILDFORD, UNITED KINGDOM - Aug 14, 2019 - Laboratories are nearly always short of space which means bulky or very heavy equipment can’t be accommodated or has to be housed away from the laboratory

Aug 14, 2019, 11:55 AM by Michael Croft

Bio-IT World At Amgen, Agnieszka Kielczewska had a problem. The AMGN12 antibody, derived from an in vivo immunization of the XenoMouse, demonstrated single digit pM affinity to the human orthologue of the target protein, but a 200-fold weaker binding to the monkey orthologue. In order to conduct toxicology studies in non-human primate species, Amgen needed that affinity difference to be closer to 10-fold.

Aug 14, 2019, 02:45 AM by Michael Croft

SHIRLEY, NY - Aug 13, 2019 - August 13, 2019, as a leading supplier and manufacturer in antibody field, Creative Biolabs recently has updated its new product types for therapeutic antibody, which has at least three types of mechanisms

Aug 13, 2019, 10:42 AM by Michael Croft

MIT Technology Review | Chipmaker Nvidia is betting that AI's language skills will advance rapidly-it's releasing a powerful tool for putting together chatty programs.

Aug 13, 2019, 10:29 AM by Michael Croft

Forbes | With the evolution of biobanks rapidly enabling the creation of massive collections of biological material and associated information, how are these collected terabytes of data transforming nations?

Aug 13, 2019, 05:01 AM by Michael Croft

RESEARCH TRIANGLE PARK, NC - Aug 13, 2019 - AskBio, the world’s foremost clinical stage and gene therapy platform company, has acquired Synpromics, the leader in gene control synthetic promoter technology, bioinformatics and intelligent data-driven design that enables more precise cell targeting and gene expression

Aug 12, 2019, 09:55 AM by Michael Croft

Bio-IT World | The global movement toward the application of genomics to medical practice is exciting because it is essentially "precision medicine come real," says Ewan Birney, chair of the Global Alliance for Genomics and Health (GA4GH). But which countries are involved? And what progress has been made so far? Bio-IT World’s overview offers an update on currently active national government-funded genomic-medicine initiatives, grouped by area of emphasis.

Aug 12, 2019, 09:19 AM by Michael Croft

PHILADELPHIA, PA, UNITED STATES - Aug 12, 2019 - Signant Health (signanthealth.com), a leading provider of technology for clinical research, today launches the Signant Health Partner Program, a significant investment the company is making to enable clinical research organizations (CROs) to better serve sponsors in the areas of Patient Data, Patient Experience, Clinical Supplies, and Endpoint Quality Solutions

Aug 12, 2019, 05:52 AM by Michael Croft

NEW YORK, NY - Aug 12, 2019 - Creative Enzymes Has Launched several enzymes services for Bio-researchers SHIRLEY, NY - Aug, 2019 - As an excellent supplier and manufacturer, Creative Enzymes recently has launched five enzymes related services, such as biocatalysis service, enzyme engineering, enzyme modification, enzyme conjugation, and enzyme formulation for researchers working in the life science field

Aug 12, 2019, 04:19 AM by Michael Croft

SHIRLEY, NY - Aug 12, 2019 - It has long been a worldwide problem to precisely identify leucine and isoleucine, not to mention 100% accuracy

Aug 9, 2019, 09:05 AM by Michael Croft

Aug 8, 2019, 11:09 AM by Michael Croft

HOPKINTON, MA, UNITED STATES - Aug 8, 2019 - Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, inflammatory diseases and certain cancers, announced that its Investigational New Drug (IND) application for a Phase 1 trial of SB 11285, the company’s intravenously (IV)-administered STING (STimulator of INterferon Gene) agonist development candidate, is now effective following clearance by the FDA

Aug 8, 2019, 10:44 AM by Michael Croft

PRINCETON, NJ - Aug 8, 2019 - The WIRB-Copernicus Group®’s (WCG™) Clinical Services Division announced the acquisition of PharmaSeek, LLC, including its wholly-owned subsidiaries PFS Clinical and PatientWise, leading providers of turn-key administrative, consulting, patient recruitment and training solutions for clinical research sites

Aug 7, 2019, 10:12 AM by Michael Croft

CAMBRIDGE, MA, US - Aug 7, 2019 - Shimmer Research, a global leader in wearable technology for research applications, today announced that it has been honored with two GHP International Life Sciences Awards – Best Clinical Trials Wearable Sensor Technology Company USA, and Best Researcher Wearable Wireless Technology Provider 2019

Aug 7, 2019, 08:09 AM by Michael Croft

WESTBURY, NY - Aug 7, 2019 - Aug. 7, 2019 - BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it will be hosting a research symposium entitled "Innovation in Immuno-oncology: Breaking Down the Barriers" on Aug

Aug 6, 2019, 13:55 PM by Michael Croft

BERLIN, GERMANY - Jul 30, 2019 - LabTwin GmbH, the world’s first voice and AI-powered digital lab assistant, today announced partnerships with CA-based life science shared lab facilities Bonneville Labs and Lab Launch

Aug 6, 2019, 10:23 AM by Michael Croft

PRINCETON, NJ - Aug 6, 2019 - Certara®, the global model-informed drug development and decision support leader, today announced the launch of BaseCase Data Manager, which allows clients to build interactive, data-driven mobile tools using real-world data sources, such as healthcare claims, costs, quality, outcomes, and population data

Aug 6, 2019, 08:43 AM by Michael Croft

WESTBURY, NY - Aug 6, 2019 - BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it has acquired Keystone Biologicals, Inc

Aug 5, 2019, 15:28 PM by Michael Croft

BEVERLY, MA, UNITED STATES - Aug 5, 2019 - Quantabio, a leading provider of robust DNA and RNA amplification reagents for the most demanding molecular testing and life science research applications, today announced the Wisconsin State Laboratory of Hygiene has adopted its technology to improve newborn screening for Spinal Muscular Atrophy (SMA) and Severe Combined Immunodeficiency (SCID)